Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans

While SARS-CoV-2 specific neutralizing antibodies have been developed for therapeutic purposes, the specific viral triggers that drive the generation of SARS-CoV-2 specific IgG and IgM antibodies remain only partially characterized. Moreover, it is unknown whether endogenously derived antibodies dri...

Full description

Bibliographic Details
Main Authors: Shuyi Yang, Keith R. Jerome, Alexander L. Greninger, Joshua T. Schiffer, Ashish Goyal
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/3/516